As of May 22
| -0.17 / -0.26%|
The 12 analysts offering 12-month price forecasts for AbbVie have a median target of 70.50, with a high estimate of 86.00 and a low estimate of 55.00. The median estimate represents a +7.67% increase from the last price of 65.48.
The current consensus among 15 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.